SCHEMBL8911552

SCHEMBL8911552

CCOC(=O)C1=Nc2cc3c(c(C)c2=C1C)-c1c(OC)ccc(OC)c1N=3

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
HSD17B2 P37059 1/20 0.36
HTT P42858 2/20 0.35
MAPT P10636 8/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
GAA P10253 3/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 4/20 0.34
HSP90AA1 P07900 1/20 0.34
HIF1A Q16665 1/20 0.34
TUBB4A P04350 1/20 0.34
TUBB P07437 1/20 0.34
TUBA3C P0DPH7 1/20 0.34
TUBA1B P68363 1/20 0.34
TUBA4A P68366 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8910413 0.77 FGB (0.41) SMN1; SMN2HTTMAPTCYP1A2CYP3A4
SCHEMBL8536893 0.76 MAPT (0.52) SMN1; SMN2NPC1RAB9AHTTMAPT
SCHEMBL8150303 0.72 MAPT (0.41) SMN1; SMN2NPC1RAB9AHTTMAPT
SCHEMBL9434365 0.72 FGB (0.42) SMN1; SMN2NPC1RAB9AHSD17B2HTT
SCHEMBL7966334 0.70 KDM4E (0.36) SMN1; SMN2RAB9AHTTMAPTNPSR1
SCHEMBL7963227 0.70 LMNA (0.36) SMN1; SMN2HTTMAPTCYP1A2CYP2C19
SCHEMBL9434368 0.70 SMN1; SMN2 (0.36) SMN1; SMN2NPC1RAB9AHTTMAPT
SCHEMBL9435019 0.69 ALDH1A1 (0.35) SMN1; SMN2NPC1RAB9AHTTMAPT
SCHEMBL9434910 0.69 HRH3 (0.37) SMN1; SMN2NPC1RAB9AHTTMAPT
SCHEMBL7965432 0.68 MAPT (0.34) SMN1; SMN2HTTMAPTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5679694-A LOW TOXICITY AGAINST NORMAL CELL LINES THE WELLCOME FOUNDATION LTD. (GB) 1997-10-21 US disclosed
WO-1994002483-A1 TETRACYCLIC COMPOUNDS PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOUR AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-02-03 WO disclosed